Pancreatitis Chronic clinical trials

Explore recruiting pancreatitis chronic clinical trials.

Recruiting pancreatitis chronic studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pancreatitis Chronic trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

COPE-CP: The effect of Celecoxib on pain, quality of life, use of opioids, and inflammation in patients suffering from chronic pancreatitis: a multicenter randomized placebo-controlled, double-blinded clinical trial

Denmark

Therapeutic confirmatory (Phase III) EU CTIS Study details

Pancreatitis Chronic trials by city

Pancreatitis Chronic in Toronto Pancreatitis Chronic in Vancouver Pancreatitis Chronic in Montreal Pancreatitis Chronic in Calgary Pancreatitis Chronic in Edmonton Pancreatitis Chronic in Ottawa Pancreatitis Chronic in Winnipeg Pancreatitis Chronic in Quebec City Pancreatitis Chronic in Hamilton Pancreatitis Chronic in Kitchener Pancreatitis Chronic in London Pancreatitis Chronic in Halifax Pancreatitis Chronic in New York Pancreatitis Chronic in Los Angeles Pancreatitis Chronic in Chicago Pancreatitis Chronic in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease